Resume

STANTON C. BURT
11177 Westminster Court
Carmel, IN, 46033
Home (317) 846-6331 • Cell (317) 809-9920 • StantonBurt@gmail.com
_____________________________________________________________________________

PROFILE

Employed for 33 years at Eli Lilly and Company in a wide variety of production, business, and contract negotiating capacities related to manufacturing and supply. For the last 10 years has designed supply chains for acquired molecules, and negotiated supply agreements supporting the business objectives of both partners. Able to integrate the larger picture objectives with operational details to achieve a seamless transition from theory through implementation. Has both cross-functional breadth of knowledge and the depth of expertise required to develop a manufacturing and supply vision. A key to communicating and reaching agreement upon that vision is the ability to convert complex ideas and scenarios into an understood and agreed upon common path forward supported by the stakeholders. Currently available for consulting or contract work.

SPECIALIZED AREAS OF EXPERTISE

________________________________________________________________________________________

Due Diligence
Has represented Manufacturing/Supply Chain in more than 30 due diligence projects assessing the acquisition difficulty, cost, and risk of multiple supply chain scenarios.

Contract Negotiations
Successfully negotiated manufacturing aspects of supply agreements with companies such as Takeda, Boehringer Ingelheim, and Daiichi Sankyo. Authored and taught in-licensing/out-licensing course for manufacturing personnel.

Alliance Management
Followed contract negotiation with fine design and operation of the supply chain with partners such as 3M, Pierre Fabre, and Daiichi Sankyo.

Supply Chain Re-Design
Post-launch modifications to supply chains including Daiichi Sankyo Europe (Evista®) and United Therapeutics (tadalafil for PAH).
________________________________________________________________________________________

EXPERIENCE

Launch Leadership

Global Supply Launch Team Leader for Evista®
Global Supply Launch Team Leader for Humalog®
Supply Launch Leader for Humulin® cartridges in the U.S.
Global Supply Launch Team Leader for Gemzar®

Manufacturing

Start-up and first Department Head of Humulin Biosynthetic Final Purification, Lilly Building 132
Department Head of Isolation, Cleavage, and Initial Purification (Humulin®) in Lilly Building 130
Start-up and first Department Head of Vancomycin Chromatography
Department Head of Biosynthetic Fermentation
Department Head of Antibiotic Fermentation and Antibiotic Initial Purification

Quality

Accepted special assignment as corporate wide Biochemical Validation Task Team Leader following Lilly FDA inspection problems
Chaired Validation Committee for IQ/OQ/PQ plan for the start-up of Humulin® Building 132
Team Leader for the cross-functional group that authored the Quality Assurance Lilly Corporate Guideline for Validation

Laboratory/Technical

Conceived, proved in the laboratory, and validated at full scale the low temperature heat kill of E. coli (as a replacement for the then current inactivation using toluene/phenol)
Validated the first large-scale (greater than 10L) recombinant DNA fermentor approved for operation by the National Institutes of Health

PATENTS, PUBLICATIONS, CERTIFICATIONS

United States Patent 4,070,247; Stanton C. Burt (sole inventor): Diagnostic Media - Isopropyl-beta-D-thiogalacto-pyranoside as a stimulator of lactose positive reaction in E. coli diagnostic media.

Co-author of article in the Journal of Industrial Microbiology titled "Sterilization of bio-reactor media on the basis of computer calculated thermal input designated as Fo"

APICS Certification in Production and Inventory Management

EDUCATION

Master of Arts - Microbiology
Indiana University • Bloomington, IN

Bachelor of Arts - Biological Sciences
Indiana University • Bloomington, IN